RU96120210A - GEL FOR TREATMENT OF SKIN DISEASES AND FOR DISINFECTION OF SKIN - Google Patents

GEL FOR TREATMENT OF SKIN DISEASES AND FOR DISINFECTION OF SKIN

Info

Publication number
RU96120210A
RU96120210A RU96120210/14A RU96120210A RU96120210A RU 96120210 A RU96120210 A RU 96120210A RU 96120210/14 A RU96120210/14 A RU 96120210/14A RU 96120210 A RU96120210 A RU 96120210A RU 96120210 A RU96120210 A RU 96120210A
Authority
RU
Russia
Prior art keywords
composition according
skin
composition
water
gelling agent
Prior art date
Application number
RU96120210/14A
Other languages
Russian (ru)
Other versions
RU2142273C1 (en
Inventor
Браун Томсен Йохи
Кристиан Меллер Енс
Original Assignee
Браун Томсен Йохи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Браун Томсен Йохи filed Critical Браун Томсен Йохи
Priority claimed from PCT/EP1995/001025 external-priority patent/WO1995025544A1/en
Publication of RU96120210A publication Critical patent/RU96120210A/en
Application granted granted Critical
Publication of RU2142273C1 publication Critical patent/RU2142273C1/en

Links

Claims (18)

1. Фармацевтическая композиция в виде геля для лечения кожных заболеваний, включающая жидкость и высокомолекулярный полимерный желирующий агент, растворенный в жидкости, отличающаяся тем, что композиция содержит более 90 вес. % низшего алканола относительно общего веса всей композиции и менее 10 вес.% воды от общего веса композиции.1. The pharmaceutical composition in the form of a gel for the treatment of skin diseases, including a liquid and a high molecular weight polymer gelling agent, dissolved in a liquid, characterized in that the composition contains more than 90 weight. % lower alkanol relative to the total weight of the whole composition and less than 10 wt.% water of the total weight of the composition. 2. Композиция по п.1, отличающаяся тем, что концентрация воды ниже равновесного количества при 20 - 24oC и при относительной влажности 50 - 100%.2. The composition according to claim 1, characterized in that the concentration of water is below an equilibrium amount at 20-24 ° C and at a relative humidity of 50-100%. 3. Композиция по п.1 или 2, отличающаяся тем, что состоит по существу только из желирующего агента, алканола и воды. 3. The composition according to claim 1 or 2, characterized in that it consists essentially only of a gelling agent, alkanol and water. 4. Композиция по п.1 или 2, отличающаяся тем, что дополнительно содержит эффективное количество агента, усиливающего действие спирта при лечении кожного заболевания и которая по существу свободна от других фармацевтически активных компонентов. 4. The composition according to claim 1 or 2, characterized in that it further comprises an effective amount of an agent that enhances the action of alcohol in the treatment of skin disease and which is essentially free of other pharmaceutically active components. 5. Композиция по п. 4, которая включает основание, предпочтительно в количестве, обеспечивающей pH 6 - 9,5, такое, как неорганическая щелочь или органическое основание, предпочтительно выбранное из гидроксида натрия и калия и триэтиламина. 5. The composition according to p. 4, which includes a base, preferably in an amount providing a pH of 6 to 9.5, such as an inorganic alkali or organic base, preferably selected from sodium hydroxide and potassium and triethylamine. 6. Композиция по любому из пп.1 - 5, отличающаяся тем, что алканол выбирают из этанола, изопропанола и их смесей, предпочтительно этанола. 6. The composition according to any one of claims 1 to 5, characterized in that the alkanol is selected from ethanol, isopropanol and mixtures thereof, preferably ethanol. 7. Композиция по любому из пп.1 - 6, отличающаяся тем, что желирующий агент представляет собой производное целлюлозы, предпочтительно эфир целлюлозы и более предпочтительно этилгидроксиэтилцеллюлозу. 7. A composition according to any one of claims 1 to 6, characterized in that the gelling agent is a cellulose derivative, preferably cellulose ether, and more preferably ethyl hydroxyethyl cellulose. 8. Композиция по любому из пп.1 - 7, отличающаяся тем, что концентрация воды составляет менее 5%, предпочтительно менее 3,3% от веса алканол плюс вода. 8. The composition according to any one of claims 1 to 7, characterized in that the concentration of water is less than 5%, preferably less than 3.3% by weight of alkanol plus water. 9. Композиция по любому из пп.1 - 8, отличающаяся тем, что она помещена в непроницаемый для влаги или влажного пара контейнер. 9. The composition according to any one of claims 1 to 8, characterized in that it is placed in a container impervious to moisture or wet steam. 10. Композиция по любому из пп.1 - 9, отличающаяся тем, что ее используют для лечения кожи, инфицированной вирусом. 10. The composition according to any one of claims 1 to 9, characterized in that it is used to treat skin infected with a virus. 11. Композиция по п.10, отличающаяся тем, что вирусная инфекция представляет собой инфекцию, вызванную вирусом Herpts simplex. 11. The composition of claim 10, wherein the viral infection is an infection caused by Herpts simplex virus. 12. Композиция по любому из пп.1 - 9, отличающаяся тем, что ее используют для лечения кожи, инфицированной эктопаразитами. 12. The composition according to any one of claims 1 to 9, characterized in that it is used to treat skin infected with ectoparasites. 13. Композиция по п.1, отличающаяся тем, что в качестве желирующего агента содержит эффективное для желирования количество этилгидроксиэтилцеллюлозы. 13. The composition according to claim 1, characterized in that the gelling agent contains an effective gelling amount of ethyl hydroxyethyl cellulose. 14. Композиция по п.15, отличающаяся тем, что ее используют в качестве фармацевтического препарата. 14. The composition according to p. 15, characterized in that it is used as a pharmaceutical preparation. 15. Способ лечения инфицированной кожи посредством местного нанесения на инфицированный участок кожи гелевой формы фармацевтической композиции, включающей полимерный желирующий агент, более 90 вес.% низшего алканола и менее 10 вес.% воды относительно общего веса композиции. 15. A method of treating infected skin by topically applying to the infected area of the skin a gel form of a pharmaceutical composition comprising a polymer gelling agent, more than 90 wt.% Lower alkanol and less than 10 wt.% Water, relative to the total weight of the composition. 16. Способ по п.17, при котором проводимое лечение достаточно эффективно для оказания воздействия на слой кожи, лежащий ниже рогового слоя. 16. The method according to 17, in which the treatment is effective enough to affect the skin layer lying below the stratum corneum. 17. Способ по п.17 или 18, при котором композиция остается в контакте с пораженным вследствие заболевания участком кожи в течение периода времени не менее 2 ч, предпочтительно не менее 4 ч с образованием прилипающей барьерной пленки, состоящей из упомянутого полимера. 17. The method according to 17 or 18, in which the composition remains in contact with the affected area of the skin for a period of time of at least 2 hours, preferably at least 4 hours with the formation of an adherent barrier film consisting of the aforementioned polymer. 18. Композиция по пп.1 - 9, отличающаяся тем, что ее используют для лечения заболеваний слоев кожи, лежащих ниже рогового слоя, посредством местного нанесения на кожу. 18. The composition according to claims 1 to 9, characterized in that it is used to treat diseases of the skin layers below the stratum corneum, by topical application to the skin.
RU96120210A 1994-03-21 1995-03-20 Gel for curing skin diseases and for disinfection of skin RU2142273C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
DK0325/94 1994-03-21
DE0325/94 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (2)

Publication Number Publication Date
RU96120210A true RU96120210A (en) 1998-12-27
RU2142273C1 RU2142273C1 (en) 1999-12-10

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96120210A RU2142273C1 (en) 1994-03-21 1995-03-20 Gel for curing skin diseases and for disinfection of skin

Country Status (26)

Country Link
US (4) US5981605A (en)
EP (1) EP0751789B1 (en)
JP (1) JP3560977B2 (en)
KR (1) KR100396278B1 (en)
CN (1) CN1146725A (en)
AT (1) ATE208212T1 (en)
AU (1) AU701872B2 (en)
BR (1) BR9507164A (en)
CA (1) CA2186045A1 (en)
CZ (2) CZ286758B6 (en)
DE (1) DE69523745T2 (en)
DK (1) DK0751789T3 (en)
EE (1) EE03293B1 (en)
ES (1) ES2168111T3 (en)
FI (1) FI963696A (en)
HU (1) HUP9774641A2 (en)
LV (1) LV12951B (en)
MX (1) MX9604208A (en)
NO (1) NO314126B1 (en)
NZ (1) NZ283135A (en)
PL (1) PL179918B1 (en)
PT (1) PT751789E (en)
RU (1) RU2142273C1 (en)
SK (1) SK281575B6 (en)
UA (1) UA41989C2 (en)
WO (1) WO1995025544A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396278B1 (en) * 1994-03-21 2003-11-28 톰슨 존 브라운 Treatment of skin diseases and skin sterilization gel
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (en) * 1995-03-28 1997-04-25 Oreal USE OF A CGRP ANTAGONIST TO TREAT CUTANEOUS REDNESS OF NEUROGENIC ORIGIN AND COMPOSITION OBTAINED
DE19624508A1 (en) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Use of propanols and butanols to treat herpes diseases
JP2001505532A (en) 1996-06-24 2001-04-24 バイオ―セイフ エンタープライジズ，インコーポレイテッド Antimicrobial composition
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
EP1295893A4 (en) * 2000-05-31 2005-10-26 Japan Science & Tech Agency SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
CN1633306A (en) * 2001-10-16 2005-06-29 阿文尼尔药品公司 Viral inhibition by n-docosanol
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (en) * 2002-05-02 2003-11-20 Wella Ag Anhydrous hair styling gels
AU2003242235A1 (en) * 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal composition
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (en) 2005-12-13 2007-06-14 Beiersdorf Ag Transparent sunscreen
NZ594545A (en) 2006-07-21 2012-12-21 Biodelivery Sciences Int Inc Transmucosal delivery devices with enhanced uptake containing fentanyl or buprenorphine
WO2008049454A1 (en) 2006-10-23 2008-05-02 Ecolab Inc. Virucidal composition
JP2010511723A (en) * 2006-12-04 2010-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Topical pharmaceutical composition
JP5028131B2 (en) * 2007-04-13 2012-09-19 花王株式会社 Gelling agent
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2008153748A1 (en) * 2007-05-24 2008-12-18 The Mclean Hospital Corporation Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (en) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Use of disinfectant comprising alcoholic active agent and further auxiliary materials and water for preoperative rapid disinfection of sebaceous gland of the skin within a time interval of less than four minutes and for germ reduction
EA013233B1 (en) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Antiseptic composition for desinfection of cutaneous covering, method for preparing thereof ana semi-product therefor
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2512231B1 (en) * 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (en) * 2011-06-22 2013-06-28 Urgo Lab FILMOGENE COMPOSITION AND USE THEREOF FOR THE TREATMENT OF HERPES
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation
EP4048237B1 (en) * 2019-10-25 2024-02-28 Mucocort AB Treatment of inflammatory condition in mucous membrane or skin with low amounts of propylene glycol

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (en) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Process for the production of cellulose ethers which are soluble in water and / or alkali
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (en) * 1978-03-31 1981-06-22 Landstingens Inkopscentral WATER-BASED SALVATION FOR SKIN INFECTION CONTAINING ALCOHOL AS DISINFECTANT
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (en) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd Base material composition and medicinal composition for external use
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (en) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach VIRUCID AGENT
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (en) * 1987-04-10 1990-06-29 Roussel Uclaf BUTYL HYDROXYANISOLES FOR USE IN THE PROPHYLACTIC TREATMENT OF RETROVIRUS DISEASES AS MODIFIERS OF RETROVIRUS INFECTIVITY AND ANTI-INFECTING PRODUCTS
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE466134B (en) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab GEL-PHARMACEUTICAL LIQUID COMPOSITION AND APPLICATION THEREOF IN PHARMACEUTICAL COMPOSITIONS
WO1993000114A1 (en) * 1991-06-20 1993-01-07 Viro-Tex Corporation Topical composition enhancing healing of herpes lesions
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
KR100396278B1 (en) * 1994-03-21 2003-11-28 톰슨 존 브라운 Treatment of skin diseases and skin sterilization gel
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Similar Documents

Publication Publication Date Title
RU96120210A (en) GEL FOR TREATMENT OF SKIN DISEASES AND FOR DISINFECTION OF SKIN
US6342537B1 (en) Gel for treatment of skin diseases and for disinfection of the skin
US5081157A (en) Compositions and in situ methods for forming films on body tissue
US5081158A (en) Compositions and in situ methods for forming films on body tissue
RU97109845A (en) ANTI-HEMORROID COMPOSITIONS AND METHOD OF APPLICATION
JP3000104B2 (en) Compositions and methods for forming a film at native sites on body tissue
RU2438654C1 (en) Hydrogel composition for treating burns
AU659623B2 (en) Treatment of topical infections
ES2182507T3 (en) THERAPEUTIC SYSTEM THAT CAN BE ACTIVATED BY HUMIDITY.
KR960700766A (en) Pharmaceutical composition consisting of sponge material in which ester derivative of hyaluronic acid is combined with other pharmaceutically effective substances
JPH05506861A (en) Compositions and methods for topical treatment of damaged or diseased tissue
AU612387B2 (en) Pharmaceutical compositions promoting the wound healing and process for preparing same
US4732755A (en) Skin burn treatment
RU2233151C2 (en) Application of tosylchloroamides for treatment of skin and mucosa disease
GB2043668A (en) Cross-linked hydroxyethyl starch
CN106937942A (en) A kind of medical skin wound analgesia gel and preparation method thereof
RU2108114C1 (en) Biological composition to treat wounds
JPH0253728A (en) Medicine for prevention of snore
RU2744545C1 (en) Agent for treatment of wounds, burns and inflammatory skin diseases
JP2723473B2 (en) Uses of sulfated saccharides
JPH0647558B2 (en) Persistent activator and method for producing the same
KR20240068459A (en) Wound Dressing by Secondary Application Containing Wound Healing Agent
EP2043663B1 (en) Topical treatment of warts
RU2203684C2 (en) Method for obtaining bandage material
RU2000125000A (en) COMPOSITION FOR ANTISEPTIC TREATMENT OF HAND SKIN AND OPERATION FIELD